Role of Omega-3 Fatty Acids in Managing Fatty Liver Disease

Current Evidence on Omega-3 for NAFLD/NASH

Omega-3 supplementation has shown inconsistent results in reducing liver fat content, with some studies demonstrating improvement while others showing no significant benefit 1, 2
A multi-center trial comparing ethyl-eicosapentanoic acid with placebo found no effect on liver enzymes, insulin resistance, or liver histology in patients with biopsy-proven NASH 2
In children, paired biopsies showed improved histological NAFLD scores after 18 months of docosahexaenoic acid supplementation 2

The European Society for Clinical Nutrition and Metabolism guidelines state with strong consensus that omega-3-fatty acids cannot be recommended to treat NAFL/NASH until further data regarding their efficacy are available 1, 2, 3
Weight loss through dietary modification and physical activity is a recommended first-line intervention for NAFLD 6, 7
A Mediterranean diet pattern is beneficial for NAFLD even when isocaloric or without weight changes 6, 5
Reduction of saturated fats, trans fats, simple sugars, and processed foods is recommended for NAFLD management 6, 8

In pediatric patients with parenteral nutrition-associated cholestasis, lipid emulsions enriched with omega-3 fatty acids can be used 9

Traditional diets have an omega-6 to omega-3 ratio close to 2:1, whereas Western diets have a ratio closer to 20:1 8
Cross-sectional studies show higher rates of NAFLD with lower intakes of oily fish rich in long-chain omega-3 fatty acids 8
Increasing dietary marine omega-3 through food sources may be beneficial, though more research is needed to assess liver-specific benefits 8
Studies have used various doses ranging from 1-4 g/day of omega-3 fatty acids 2
A trial using 4 g of omega-3 fatty acids showed a trend toward improvement in liver fat in patients with NAFLD 2
When combined with other interventions, omega-3 supplementation may be more effective in lowering intrahepatic lipid 2